Skip to main content
Premium Trial:

Request an Annual Quote

Ghostwriting: Great for Biographies, Bad for Scientific Papers

Derek Lowe at In the Pipeline brings us this cheery news: a recent JAMA report concludes that a number of papers published by Merck on its Vioxx drug were written by the company, which then tacked on some academic names to make them look more credible. "There seems little doubt that this practice does go on," writes Lowe, noting that Merck is certainly not the only company to employ such methods. "But the worst of these Merck cases look like a search for a lead author or co-author, which is just unacceptable."

GTO's question is, if Merck was shopping for an author, who was willing to sell out?


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.